CAR-T Therapy for BCMA: Market Overview and Growth Drivers
The CAR-T therapy segment of the BCMA-targeted therapies market is experiencing rapid growth, driven by innovation in gene editing, regulatory support, and the success of therapies like Abecma. With further research and investment, CAR-T therapy is positioned to play an essential role in t
